Digital Coming soon: New EU Artificial Intelligence Act Everyone is talking AI these days – and regulators are taking notice.
Digital AI is coming and regulators are getting prepared The UK’s MHRA recently published its guidance on its approach to both regulating the use of AI for drug and medical devices, and how it can utilise the technology to improve its regulating
R&D Psychedelic treatments on cusp of approval, but questions re... There is a new wave of psychedelic treatment moving through clinical trials targeting mental health conditions, and they are showing strong efficacy.
Digital Considering current legal risks from the use of AI in the li... The use of artificial intelligence (AI) in the life sciences sector is increasing, and its applications may be transformative.
R&D Integrating pharmaceutical functions: Using quality insights... As the life sciences field becomes more complex, it is apparent that many aspects of product quality and safety processes are inextricably linked
Digital The evolution of computer validation from being on premises ... Regulation and the pharmaceutical sector are intrinsically linked.
News Novartis raises mid-term sales outlook on pipeline promise Novartis has raised its guidance for sales growth out to 2029 on the strength of its pipeline and the potential of late-stage R&D assets
Sales & Marketing Coming soon: The Life Sciences Industry Report 2025 – insigh... Prepare for 2025 with pharmaphorum’s Life Sciences Report, featuring expert insights on AI in drug development, gene therapy, and top industry trends
